Marathon gains in oil stocks after beating earnings forecasts on strong demand
Text size Marathon Petroleum’s Los Angeles refinery in Carson, California. Bing Guan/Bloomberg Marathon Petroleum ‘c quarterly earnings and revenue jumped above expectations thanks to limited refining capacity and strong demand…
Tesla shares are down after a blowout in July as the stock’s vote is divided
Text size Tesla’s shareholder meeting is on Thursday. Nicolas Asfouri/AFP via Getty Images Tesla shares fell on Tuesday amid a wider decline in stock markets as a crucial shareholder meeting…
Digital Transformation: Rethinking Clinical Trial Management – MedCity News
Even before Covid-19 disrupted the traditional model for clinical trials, researchers were harnessing the power of technology to make trials more accessible and improve data collection. The movement has coalesced…
Stocks retreat as tensions rise in Taiwan
Text size House Speaker Nancy Pelosi is scheduled to arrive in Taiwan on Tuesday. Chip Somodevilla/Getty Images Stocks fell on Tuesday amid rising geopolitical tensions as House Speaker Nancy Pelosi…
BP hikes dividends, buybacks as profits rise amid high prices
(Bloomberg) — BP Plc raised its dividend and accelerated share buybacks to their fastest pace after earnings jumped. Most Read by Bloomberg The oil and gas industry is boosting shareholder…
Pelosi’s trip to Taiwan is raising alarm in global financial markets
(Bloomberg) — Traders braced for the expected arrival of U.S. House Speaker Nancy Pelosi in Taipei on Tuesday to raise tensions with China, sending stocks lower and global havens the…
Auburn signs four-star guard Aden Holloway
Auburn earned its first commitment of the 2023 recruiting cycle as a four-star guard, Aden Holloway from Prolific Prep in California. Holloway chose Auburn on Monday night Tennessee. He also…
With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis – MedCity News
FDA approval of Arcutis Biotherapeutics’ new drug for plaque psoriasis allows the company to implement a strategy it believes will win both payers and patients — lower prices. Arcutis has…